PeptideDB

LIMK1 inhibitor BMS-4

CAS: 905298-84-2 F: C23H23N7O2S W: 461.54

LIMK1 inhibitor BMS-4 is a LIM Kinase (LIMK) inhibitor targeting to LIMK1/2. LIMK1 inhibitor BMS-4 inhibits phosphorylat
Sales Email:peptidedb@qq.com

This product is for research use only, not for human use. We do not sell to patients.

Bioactivity LIMK1 inhibitor BMS-4 is a LIM Kinase (LIMK) inhibitor targeting to LIMK1/2. LIMK1 inhibitor BMS-4 inhibits phosphorylation of cofilin, the LIMK substrate. However, LIMK1 inhibitor BMS-4 is noncytotoxic on A549 cells[1][2].
Invitro LIMK1 inhibitor BMS-4 (compound 4) (0.014-10 μM; 24 h) 在体外抑制 LIMK 而不影响 A549 细胞存活或增殖[1]。LIMK1 inhibitor BMS-4 (0.014-1 μM; 2 h) 在 A549 人肺癌细胞中抑制 LIMK 底物 cofilin 的磷酸化[1]。
Name LIMK1 inhibitor BMS-4
CAS 905298-84-2
Formula C23H23N7O2S
Molar Mass 461.54
Appearance Solid
Transport Room temperature in continental US; may vary elsewhere.
Storage
Powder -20°C 3 years
4°C 2 years
In solvent -80°C 6 months
-20°C 1 month
Reference [1]. Collins R, et al. Comparative Analysis of Small-Molecule LIMK1/2 Inhibitors: Chemical Synthesis, Biochemistry, and Cellular Activity. J Med Chem. 2022 Oct 27;65(20):13705-13713. [2]. Ross-Macdonald P, et al. Identification of a nonkinase target mediating cytotoxicity of novel kinase inhibitors. Mol Cancer Ther. 2008 Nov;7(11):3490-8.